Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,628 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 904
Recruiting: 506
Ph III recruiting: 46
Growth YoY: +21.9%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 201–205 of 205 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06403735	A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors	recruiting	Phase 1	250	Qilu Pharmaceutical Co., Ltd.INDUSTRY	1	May 8, 2024	clinicaltrials
NCT06245330	A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors	recruiting	Phase 1 / Phase 2	180	Ascentawits Pharmaceuticals, LtdINDUSTRY	1	Feb 7, 2024	clinicaltrials